Baiyunshan's Penicillin Sodium Injection Achieves Generic Drug Equivalence

Stock News
02/11

Baiyunshan (00874) announced that its subsidiary, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd., recently received approval from the National Medical Products Administration for its supplemental drug application. The 0.96g (1.6 million units) injection of penicillin sodium has passed the consistency evaluation for generic drug quality and efficacy. Penicillin sodium injection is used to treat various infections caused by susceptible bacteria, such as abscesses, bacteremia, pneumonia, and endocarditis. Penicillin is the preferred treatment for infections including hemolytic streptococcus infections, pneumococcal infections, non-penicillinase-producing staphylococcal infections, anthrax, tetanus, gas gangrene and other clostridial infections, syphilis (including congenital syphilis), leptospirosis, relapsing fever, diphtheria, and when combined with aminoglycosides for treating streptococcus viridans endocarditis.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10